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SUMMARY. A unique mutant form of erythrocyte pyruvate kinase has been found 
associated with chronic haemolytic anaemia in a child who is apparently doubly 
heterozygous for the mutant isoenzyme and for pyruvate kinase deficiency of the 
classical quantitative type. Clinical and laboratory findings conformed closely to 
those typically observed in homozygous pyruvate kinase deficiency anaemia. 
Assayed in fresh haemolysates, the isoenzyme exlubited reduced optimal activity 
(c 45% of normal) and an increased Michaelis constant for phosphoenolpyruvate 
(four to five times greater than normal). The kinetic anomaly was only partially 
corrected by activation with fructose-I,&&sphosphate. Despite some common 
characteristics, this isoenzyme appears distinct from others reported in the literature 
and lends support to the polymorphous nature of heritable haemolytic anaemias 
secondary to defective pyruvate kinase. 
Pyruvate kinase (PK) (ATP :pyruvate phosphotransferase, EC 2.7.1.40) catalyses the conver- 
sion of phosphoenolpyruvate (PEP) and adenosine &phosphate (ADP) to pyruvate and 
adenosine triphosphate (ATP). This constitutes a critical ATP regenerating reaction in 
mature human erythrocytes which must rely almost exclusively upon glycolysis to ful- 
fil energy requirements. Homozygously inherited deficiency of the enzyme is often the only 
definable biochemical lesion in cases of congenital nonspherocytic haemolytic anaemia. No 
longer entirely tenable, it was the initial presumption that haemolysis occurred in such cases 
when the quantity of functional enzyme had been degraded to levels incompatible with 
effective glycolysis. More recent evidence indicates that abnormal isoenzymes of PK also 
exist which may be associated with haemolytic anaemia despite being highly active in vitro 
under optimal assay conditions. One such isoenzyme demonstrated markedly impaired 
kinetics with an elevated Michaelis-Menten constant (K,,,) for one of its substrates, PEP 
(Paglia et al, 1968). It was postulated that this mutant enzyme might be as rate limiting in 
glycolysis as normal PK which was quantitatively deficient, since in both instances intra- 
cellular PEP concentrations would have to rise appreciably before effective catalysis could 
occur. 
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The present report summarizes clinical, haematologic and biochemical findings in another 
family which appears to be af€licted in a similar, yet clearly distinct manner. The maternal 
side harbours an abnormal PK isoenzyme of a type not previously reported. Heterozygous 
PK deficiency of the classical form exists in paternal relatives, including the father. By virtue 
of simultaneous mheritance of the paternal gene resulting in quantitatively deficient activity 
and the mutant maternal allele, the proband is presumed to have erythrocytes which contain, 
in effect, only the mutant isoenzyme. The latter was characterized by low optimal activity 




The proband was a 7-yr-old male of English-Irish ancestry who was born at full term 
following an uncomplicated pregnancy and delivery. Jaundice was apparent immediately, 
with bilirubin elevated to 6.3 mg/Ioo ml, of which 0.9 mg/Ioo ml was direct-reacting. 
Haemoglobin was I I .g g/ 100 ml, and there were 76 nucleated erythrocytes per IOO leucocytes. 
An exchange transfusion was performed on the first day of life, although no blood group 
antigen incompatibilities could be demonstrated. 
The patient remained asymptomatic until the onset ofpallor at the age of 14 mth. At 3 mth 
of age, Hb was 5.9 g/Ioo ml, reticulocytes totalled 11.8%, and there were 6 nucleated erythro- 
cytes per IOO leucocytes. Antiglobulin tests were negative. Autohaemolysis was increased 
and only partially corrected by glucose. Osmotic fragility studies and screening tests for 
G6PD, PK, and glutathione reductase deficiencies were also normal. Peripheral blood leuco- 
cytes totalled 14 500/p1 with a normal differential count, and platelets appeared normal. 
Infancy and early childhood were characterized by chronic haemolytic anaemia, occasional 
icterus, and progressive hepatosplenomegaly. Transfusions were required at 2-3 mth intervals 
when Hb levels fell to c 5 g/Ioo ml. Reticulocyte counts were generally elevated to 15-20%. 
Haemoglobin electrophoresis and alkali denaturation showed 3.8-4.7% Hb F in the proband 
and no abnormal haemoglobins in the parents. By the age of 6 yr, the liver and spleen 
extended 3 cm and 10 cm below their respective costal margins. Height, weight and develop- 
ment remained within normal limits for his age. 
Because of abdominal discomfort and indications of progressive hypersplenism, splenec- 
tomy was performed at the age of 63 yr. A total of 9 1. of packed red cells had been given up 
to that point. Antiglobulin tests were still negative. The spleen weighed 800 g and was 
characterized by prominent red pulp with moderate littoral cell hyperplasia and scattered 
haemosiderin-laden macrophages. In the year following splenectomy, he required no further 
transfusions. Haemoglobin levels fluctuated between 9.2 and 10.4 g/Ioo ml, leucocytes 
between 6000 and 11 goo/pl, and platelet counts were c 540 ooo/pl. 
There was no history of anaemia or jaundice in any blood relative, including an older 
sibling, and there was no evidence of consanguinity. 
Procedures 
Venous blood specimens from family members and normal controls were anticoagulated 
by heparin, refrigerated with ice, and shipped from Ann Arbor, Michigan, to Los Angeles 
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for processing within 48 hr. Five-millilitre aliquots of fresh blood were also precipitated by 
immediate mixture with 10 m10.6 N perchloric acid for determination of adenine nucleotide 
and glycolytic intermediate concentrations by the methods of Minakami et a1 (1965). A 
modification of Krimsky's (1963) method was used to measure z,3-diphosphoglycerate. 
To prepare cells for enzyme assays, heparinized specimens were mixed with 0.25 vol 5% 
polyvinylpyrrolidone (Plasdone C, Antara Chemicals, General Aniline and Film Corp., 
Los Angeles, Calif.) and allowed to stand at room temperature. As erythrocytes settled, the 
supernate, containing mostly platelets and leucocytes, was aspirated free and preserved. 
Sedimented erythrocytes were washed once with 5 vol cold isotonic saline and centrifuged 
at 450 g for 10 min. Packed erythrocytes were drawn into a sterile plastic syringe containing 
an equal volume of compressed nylon wool (FT-242, scrubbed nylon fibre, Fenwal Labora- 
tories, Morton Grove, Ill.) and warmed in an incubator to 37°C for 30 min, with periodic 
remixing of the contents by rotation. This allowed most remaining granulocytes to contact 
and adhere to nylon fibres, yielding red cell preparations minimally contaminated with 
leucocytes. After incubation, erythrocytes were discharged from the syringe and washed 
twice with 10 vol cold isotonic saline, and centrifuged at 450 g for 10 min after each wash. 
Packed cells were diluted with saline to final concentrations of c 3 x 10~1~1.  Exact concentra- 
tions were determined by quadruplicate measurements with a Coulter Model F Counter, and 
the number of remaining leucocytes in each red cell preparation was determined by duplicate 
haemocytometer counts. 
Leucocytes in the supernate preserved from the initial sedimentation procedure were 
similarly packed, washed twice with 30 mI cold isotonic saline, and centrifbged as before. 
Washed leucocytes, now virtually free of platelets but variably contaminated with ery- 
throcytes, were diluted with saline to c 4x 10~1~1. Final counts were determined in 
quadruplicate with the Coulter Counter. 
Enzyme assays were performed using fresh cell lysates prepared by dilution in buffered 
saline or water and thrice frozen and thawed with a Dowanol and solid C02 freezing bath. 
Assays of glycolytic, pentosephosphate pathway and ancillary enzymes were performed by 
procedures delineated elsewhere (Koutras et al, 1964; Schneider et al, 1965; Valentine et al, 
1967, 1969,1970; Pagfa & Valentine, 1967; Baughan et d, 1968). 
Pyruvate kinase activity was determined by the method of Bucher & Pfleiderer (1955) as 
modified in a previous report (Valentine & Tanaka, 1966). The standard assay system em- 
ployed 2.0 m~ PEP, 0.4 m~ ADP, 8.0 m~ MgSO,, 0.2 m~ reduced nicotine adenine 
dinucleotide (NADH), 6 units/& lactate dehydrogenase (LDH), and 75 m~ KCI in 8.3 mM 
triethanolamine hydrochloride buffer at a final pH of 7.2+ 0.1. An identical system containing 
only 0.4 m~ PEP was assayed simultaneously. Pyruvate formed from PEP by the PK reaction 
was immediately converted to lactate by the crystalline LDH with consequent oxidation of 
NADH. The latter was observed by monitoring the time sequence of absorbence changes at 
340 mp using a Gilford multiple sample absorbence recorder, Model 2000. Reagent blanks 
devoid of haemolysate were assayed at each PEP concentration used, and the resultant values 
(usually almost negligible) were subtracted from activities observed in complete systems. 
Enzyme units (u) were defined as the number of micromoles of NADH oxidized each 
minute by 10" cells at  37°C. 
Apparent PK Michaelis constants for PEP were determined at two different concentrations 
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of ADP, 0.4 and 1.0 m ~ .  Phosphoenolpyruvate concentration was varied between 0.1 and 
10.0 m ~ .  Michaelis constants for ADP were measured using 2.0 m~ PEP and ADP concen- 
trations between 0.1 and 10.0 m ~ .  Values for K,,, were obtained by extrapolation of twelve- 
point Wolff plots and confirmed by determination of substrate concentrations coinciding 

























Haematologic values obtained on family members during the 9 mth study period are 
summarized in Table I. The proband was persistently anaemic despite periodic transfusions 






Paternal aunt (11-1) 
Maternal uncle (11-4) 
Maternal grandmother (1-4) 
Paternal grandmother (1-2) 
































* Genealogy designation according to Fig 6. 
and consistent reticulocytosis, but anaemia was not apparent in any relative. Low levels of 
peripheral leucocytes had been a common fmding in this patient for almost 4 yr, and platelet 
counts were also slightly reduced during this period. The proband's erythrocytes exhibited 
moderately severe anisopoikilocytosis with frequent schistocytes and pyknocytes. Leucocyte 
morphology and differential counts were normal. 
Glycolytic Intermediates and Adenine Nucleotides 
Peripheral blood concentrations of glycolytic intermediates were measured in the patient 
and his parents and found to be normal in the latter. In the proband's specimens, however, 
marked elevations of some intermediates were demonstrable, most prominently the phos- 
phoglycerates, PEP, and hexosemonophosphates, which were three to five times normal 
mean levels. The pattern of intermediate elevations was remarkably similar to that seen in 
classical homozygous PK deficiency as shown in Fig I, which demonstrates further that 
these changes were not simply a consequence of reticulocytosis. Blood ATP concentrations 
were reduced in the proband, and the ATP/ADP ratio was reversed. 
Erythrocyte Enzyme Activities 
Fig 2 presents relative profiles of various enzyme activities in freshly prepared crude 
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haemolysates. Elevated catalytic rates in proband haemolysates correlated well with the 
activity increases characteristic of specimens with young mean cell ages. The notable excep 
tion was PK, which approximated 40% of normal mean activities and only 20% of that 
expected in a specimen with this degree of reticulocytosis. The only abnormality in parental 
enzyme activities was a similar reduction of PK to 4~60% of normal rates. Activity decre- 
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FIG I. Relative concentrations of peripheral blood glycolytic intermediates and adenine nucleotides. 
Mean laboratory values for normal subjects are represented by the horizontal line at a multiple of I. 
Broken curves, labelled 'PK deficiencies' (0) and 'Reticulocytosis' (m) respectively, represent mean 
values from simultaneous assays of two cases with classical homozygous PK deficiency anaemia and 
from six cases with a mean reticulocyte count of 8.8% induced by causes other than erythroenzymo- 
pathies. Compounds abbreviated along the abscissa are in order: glucose-6-phosphate, fructose-6- 
phosphate, fructose-r,6-disphosphate, dihydroxyacetone phosphate, glyceraldehyde-3-phosphate, 
2,3-diphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate, pyruvate, 
lactate, and adenosine triphosphate, diphosphate and monophosphate. 
almost always devoid of accelerated haemolysis. By comparison, V,,, in anaemic patients 
with homozygous deficiency is usually less than 20% of normal mean. 
Activities at 2.0 mM PEP are a close reflection of PK V,,, for normal erythrocytes under 
these assay conditions. As shown in Table 11, all members of the immediate family, as well as 
the paternal grandmother and aunt, had values compatible with heterozygous PK deficiency. 
Activities were marginal in some relatives, but were interpretable with greater certainty 
when compared with their accompanying controls. 
Measurement of PK activities both at low and high substrate concentrations (e.g. 0.4 and 
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2.0 m~ PEP) has been found to be a useful screening technique for detection of kinetic 
abnormalities (Paglia et al, 1968). Ratios of activities at these two concentrations are consis- 
tently greater than 0.7 with normal PK and may be reduced below 0.2 for some mutant forms 
of PK which are incapable of catalysing effectively under conditions of low substrate avail- 
ability. Applying this index, the proband’s activity ratio of 0.50 was found to be distinctly 
abnormal, as was the maternal value of 0.55, suggesting the presence of anomalous PEP 
kinetics. Ratios for all other family members were w i t h  normal limits. 
GPI ALD G3PD PGM PK G6PD DPS G P  
FIG 2. Relative activies of various erythrocyte enzymes. Mean laboratory values for normal subjects 
are represented by the horizontal line at a multiple of I. The broken curve labelled ‘Reticulocytosis’ 
describes mean values derived from 17 cases of haemolytic anaemia exclusive of erythroenzymopathies 
with a mean reticulocyte count of 11.2%. Enzymes abbreviated along the abscissa are in order: 
hexokinase, glucosephosphate isomerase, phosphofruaokinase, aldolase, triosephosphate isomerase, 
glyceraldehyde-pphosphate dehydrogenase, phosphoglycerate kinase, 3-phosphoglyceromutase, 
enolase (phosphopyruvate hydratase), pyruvate b a s e  (assayed at 2.0 m~ PEP and at 0.4 m~ PEP), 
lactate dehydrogenase, glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, 
combined enzymes of the distal pentosephosphate pathway, glutathione reductase, glutathione 
perofidase and glyoxalase. 
F~uctose-I ,6-diphosphate EJect in Standard PK Assay System 
Significant activation of both proband and control PK activities was apparent over a broad 
range of FDP concentrations when availability of PEP was suboptimal (Fig 3). The two 
isoenzymes responded to variable FDP concentrations in a similar manner under these con- 
ditions, but the magnitude of response was considerably greater for proband PK. Concen- 
trations greater than I m~ FDP may induce inhibition of PK activity. Consequently, the 
concentration of 0.1 ~YIM FDP was selected to provide optimal activation of both normal and 
mutant isoenzymes for comparative purposes. 
Addition of 0.1 flz~ FDP to the standard assay system slightly enhanced PK activities at 
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was notable, however, that proband and maternal values at the higher substrate concentration 
were increased approximately 40% by the activator, while increases in all other instances 
more closely approximated 10%. The overall effect in each case was to alter activity ratios 
upward toward more clearly normal values. 
Leucocyte PK determinations are subject to considerably more variation, normals in our 
laboratory ranging from c 750 u to 2100 u. Values included in Table I1 indicate that proband 
activities were marginally low, but this did not appear to be a significant deviation and may 
have been a reflection of contamination of the white cell preparations with nucleated ery- 
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FIG 3 .  PK activation by varying concentrations of fructose-I,6-&phosphate in haemolysates from the 
proband and a normal control. To accentuate FDP activation, assays were performed using 2.0 mM 
ADP and a suboptimal concentration of PEP (0.4 m ~ ) .  
subjects studied, and addition of FDP to the reaction medium seemed to result in somewhat 
lessened PK activities. 
Kinetics of Erythrocyte Pyriivate Kinase 
Kinetic curves characteristic of PK in proband and parental haemolysates are presented 
in Fig 4. For comparative purposes, a mean curve derived from accompanying control 
specimens is included. Usually, rapid increases in reaction rates are observed with only slight 
elevations in substrate concentration until V,,, is achieved at 1.0-2.0 m~ PEP. In sharp 
contrast, the proband curve was markedly skewed by a prolonged ascending limb. V,,, 
was less than half normal mean values and was not reached until PEP concentration was t 5 
m. The maternal curve was similar to that of the proband, but activities at corresponding 
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substrate levels were uniformly higher and V,,, may have been achieved somewhat sooner 
(3-4 mM PEP). 
Kinetics in paternal haemolysates more closely approximated those of subjects with classical 
heterozygous PK deficiency. V,,, was slightly over half normal mean, but there was no 
impairment of activity with substrate deprivation as in the case of the proband and his 
mother. 
Kinetic curves were developed for other relatives and their corresponding controls, 
affording more accurate determinations of V,,, and apparent K, (PEP) in each instance. 
Table I11 records mean & (PEP) obtained from Wolff plots and confirmed by linear co- 
ordinate curves. Michaelis constants were interpretable as normal in all family members 
3 -  
r 
Control .\. /'\.-.- /' - 1  
PEP concenlrotion (mM) 
FIG 4. PK kinetic curves with PEP as the variable substrate. Arrows indicate points of half maximal 
PK activities which correspond to K, (PEP) values on the abscissa. 
except the proband and his mother in whom significant elevations occurred. The maternal 
value was intermediate between those of the proband and normals. An uncle and 
grandmother were the only other maternal relatives available for study, and their K, (PEP) 
values were normal. 
Optimal PK activities, defined by kinetic curve plateaus, were unequivocally normal only 
in the paternal grandfather and maternal grandmother. All members of the immediate family 
displayed V,,, values lowered into the range associated with classical heterozygous PK 
deficiency, i.e. c 50% of mean normal activity. Values which were marginally low were 
obtained on specimens from the paternal aunt and grandmother, but these two subjects were 
more convincingly deficient when compared with normal control specimens shipped and 
processed simultaneously. 
Erythrocyte PK kinetic curves for PEP were redetermined with ADP concentration 
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TABLE 111. Maximum PK reaction velocities and Michaelis constants for phosphoenolpyruvate 
Subject 




Paternal aunt (11-1) 
Maternal uncle (11-4) 
Maternal grandmother (1-4) 
Paternal grandmother (1-2) 
Paternal grandfather (1-1) 
Shipped controls (mean of six) 
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elevated to 1.0 m ~ .  Both V,,, and K, (PEP) values were uniformly elevated to almost 
twice those obtained using 0.4 nm ADP, but the distinctions among proband, kindred and 
normals remained unaltered. 
Fructose-1,6-diphosphate Efect on Pyruvate Kinase Kinetics 
As shown in Fig 5 ,  addition of 0.1 mM FDP to the reaction system enhanced the activity 
of normal PK most prominently when PEP availability was restricted. This occurs whether 
FIG 5. Effect of fructose-I,6-disphosphate activation on PK kinetics. Broken curves were derived 
from identical haernolysates assayed simultaneously in the presence of 0.1 m~ FDP. Arrows denote 
points of half maximal PK activity and K,,, (PEP). 
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the red cells under study are obtained from normal controls or from subjects with classical 
homozygous or heterozygous PK deficiency. Activation by FDP is less pronounced at higher 
PEP concentrations, thereby elevating V,,, only slightly (10-1 5 % ) .  The resultant kinetic 
effect is to decrease K, (PEP) by t 50% (Table 111). 
PK in haemolysates from all subjects studied conformed to this expected pattern of kinetic 
behaviour, except in those from the proband and perhaps his mother as well. In the presence 
of FDP, proband V,,, increased more appreciably (70%), and K, (PEP) was reduced by 
50% but remained distinctly abnormal (0.42 111~). Maternal PK V,,, increased almost 25%, 




Shipped controls (mean of four) 
Erythrocyte Pyruvate Kinase Kinetics for Adenosine Diphosphate 
No abnormalities of K, (ADP) were found, but distinctions between normal and kindred 
V,,, values were accentuated when ADP served as the variable substrate (Table IV). Com- 





TABLE IV. Maximum PK reaction velocities and Michaelis constants for adenosine diphosphate 









about one-half and that of the proband to one-fourth. Differences in FDP effect on V,,, 
were also amplified. Normal PK activity was increased only slightly in the presence of the 
activator, whereas proband PK activity virtually doubled. Activation of maternal PK was 
again intermediate in degree. FDP had no appreciable effect on K, (ADP) for any of the 
subjects studied. 
DISCUSSION 
Whether considered from a clinical or a molecular viewpoint, it has become progressively 
more certain that PK deficiency anaemias encompass a heterogeneous group of inherited 
defects. Phenotypic expression has been noted to vary considerably among different families 
and also among affected persons within the same family (Tanaka & Valentine, 1968). The 
cases reported by Zuelzer et al (1968) were especially notable in this regard, with severely 
affected propositi and clinically normal relatives all demonstrating comparable levels of PK 
activity compatible with homozygous deficiency. A broad spectrum of expression has been 
noted not only for clinical severity but also for biochemical characteristics such as intracellular 
ATP, ATP stabilities, glycolytic intermediates, NAD/NADH ratios, glucose consumption, 
and lactate production (Keitt, 1966). 
The present case is typical of an expanding group which exhibits virtually all the clinical 
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and laboratory features commonly associated with homozygous PK deficiency except for the 
critical finding of normal or intermediately depressed PK activity on biochemical assay. 
Specifically, the patient had a lifelong history of chronic haemolytic anaemia and spleno- 
megaly without evidence of spherocytosis, antiglobulin reactions, or haemoglobinopathies. 
Erythrocyte osmotic fragility was normal, but autohaemolysis was elevated in a manner 
conforming to the Type 11 category of Selwyn & Dacie (1954). Increased concentrations of 
glycolytic intermediates were typical of those commonly found in erythrocytes with defect- 
ive PK catalysis, as were reductions in cellular ATP and concomitant increases in ADP. 




FIG 6.  Genealogy of kindred C. The proband is marked by an arrow. Males and females are indicated 
by squares and circles, respectively. Heterozygosity for quantitative PK deficiency of the usual type 
is noted by partially blackened symbols. Shading indicates heterozygosity for the mutant allele. The 
maternal grandfather (1-3) is deceased and only presumed to be a heterozygote for the mutant 
isoenzyme. 
Despite these similarities to quantitative PK deficiency anaemia, assays of proband haemo- 
lysates failed to reveal activity reductions sufficient in magnitude to support the diagnosis. 
Instead of expected depressions to c 10% of normal mean activities, proband V,,, values more 
closely approximated 40%. Kinetic studies, however, established the unique nature of PK 
in proband erythrocytes, revealing markedly impaired catalysis when PEP was progressively 
diluted. The Michaelis constant for this substrate was elevated to five times the normal mean 
value. Kinetics for the other substrate, ADP, were unaltered, suggesting that the mutational 
change in the enzyme affected only the PEP binding site. PEP kinetics intermediate between 
normal and proband were demonstrable in the mother, whereas the father and all other 
relatives studied appeared entirely normal on this basis. 
These findings were consistent with the presence of two distinct genes for erythrocyte PK 
in this family. Paternal relatives were affected with heterozygous PK deficiency of the usual 
quantitative type with half normal V , , ,  values and totally normal kinetics, a defect identifi- 
able in three generations (Fig 6).  The mother (and presumably the deceased maternal grand- 
father) had PK characteristics suggestive of heterozygosity for normal PK and the mutant 
isoenzyme: moderately elevated K, (PEP) and slightly reduced V,,, . 
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The PK complement of proband cells was apparently limited in large measure to the 
mutant isoenzyme, characterized by markedly elevated &, (PEP) and moderately reduced 
V,,,. This is assumed to result from simultaneous inheritance of the paternal gene determi- 
nant of quantitative deficiency and the mutant maternal allele. The ultimate effect, induction 
of premature haemolysis, seems most likely to be a consequence of ineffective catalysis by the 
mutant isoenzyme at the low PEP concentrations usually prevalent within erythrocytes. 
Phenotypic expression is thus identical with that which results from severe quantitative 
decreases in normal enzyme, since both essentially produce the same perturbation in glycoly- 
sis and impairment of ATP regeneration. 
We are unaware of reported instances of PK isoenzymes which were clearly identical with 
that in the present case and presume that this simply represents one more example of molec- 
ular polymorphism characteristic of this erythroenzymopathy. Several mutant forms have 
now been identified which vary significantly in their kinetics and responses to FDP activation 
and additionally in such properties as pH optima, stabilities, and electrophoretic mobilities 
(Tanaka & Paglia, 1971). Several cases have exhibited comparable increases in K, (PEP), 
but, in contrast to the present case, concomitant increases in V,,, were also observed when 
much higher PEP concentrations were employed (Paglia et al, 1968; Tanaka, 1969; Ohyama 
et a!, 1969; Boivin et al, 1969). Additionally distinctive, FDP activation in two of these 
families did not significantly affect V,,,, but converted K, (PEP) to virtually normal values 
(Tanaka, 1969; Paglia & Valentine, 1971). In another family recently restudied by Munro & 
Miller (1970) the kinetic anomaly was exaggerated by FDP activation, and reaction rates 
were a dependent variable of PEP concentration over such a broad range that satisfactory 
measurements of V,,, were not possible in the presence of the activator. The peculiarities of 
the latter observations may have been partially an effect of enzyme purification procedures, 
since these are known to alter kinetic and reaction characteristics for erythrocyte PK in some 
instances (Wiesmann & Tonz, 1966; Boivin & Galand, 1968). 
Perhaps more comparable to the present case are those reported by Waller & Lohr 
(1964) and by Lohr et a1 (1968). In the former, K, (PEP) was noted to be two to four times 
greater than normal in two cases, but V,,, was less than 10% of normal mean. The family 
in the latter study was found to have a similar elevation in K, (PEP), but the affected proband 
had a V,,, approximating 40% of normal. Electrophoretic variations were also noted, but 
FDP activation analyses were not performed. 
Mentzer & Alpers (1971) have also studied cases of elevated K, (PEP) partially corrected 
by FDP and coexisting with either normal or decreased PK activities, but details of these 
investigations are not yet available. 
Much of the difficulty in deciding which of all these cases represent truly distinct iso- 
enzymes, and which may be identical, is due to considerable variation in assay techniques. 
While many investigators have employed crude haemolysates in their studies, others have 
used preparations partially purified by a variety of methods, and it is apparent that purification 
procedures in themselves can variably alter kinetic qualities of erythrocyte PK. Nonetheless, 
it is clear that diverse mutant forms of this enzyme do exist, and, since they all accompany a 
common clinical syndrome, they provide strong evidence to support a basic pathophysiologic 
role for glycolytic enzymopathies in the induction of premature haemolysis. 
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